<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> is the second most common malignant disease in developed countries, with about one million new cases worldwide every year, accompanied with high mortality rate </plain></SENT>
<SENT sid="1" pm="."><plain>We examined the survival rate and recurrence (occurrence of distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> and/or local recurrence) of patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in Primorsko-Goranska and Istarska County who received adjuvant chemotherapy, compared to those who did not in the period since 1980. until 1999 </plain></SENT>
<SENT sid="2" pm="."><plain>This study involves 483 patients with <z:e sem="disease" ids="C0677948" disease_type="Neoplastic Process" abbrv="">colorectal cancer stages II</z:e> and III of Primorsko-Goranska and Istarska County, which were underwent curative resections of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> at the Clinical Hospital Centre Rijeka, and then treated with chemotherapy (288) or without Chemotherapy (195) </plain></SENT>
<SENT sid="3" pm="."><plain>We analyzed the five year survival rate and the recurrence of malignant disease in the adjuvant treatment group in comparison with not treated group with chemotherapy, depending on the stage of disease, degree of histological differentiation, patient age and location of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (colon or rectum) </plain></SENT>
<SENT sid="4" pm="."><plain>After follow-up of 60 months died 44.79% (129/288) of patients who received chemotherapy and 53.33% (104/195) of patients who did not receive chemotherapy </plain></SENT>
<SENT sid="5" pm="."><plain>The relative risk of <z:hpo ids='HP_0011420'>death</z:hpo> (from any cause) in chemotherapy-treated group versus the group without chemotherapy was 0.82 (p &lt; 0.008) </plain></SENT>
<SENT sid="6" pm="."><plain>Recurrence of malignant disease in the chemotherapy group was 38.54% (111/288), and in the group without chemotherapy was 46.15% (90/195) </plain></SENT>
<SENT sid="7" pm="."><plain>The relative risk of recurrence of malignant disease in the chemotherapy group versus the group without chemotherapy was 0.78 (p &lt; 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>There was no difference in treatment efficacy regard to the localization of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, but there were differences in efficiency with respect to disease stage, grade and age </plain></SENT>
<SENT sid="9" pm="."><plain>Chemotherapy with <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> and leukovorin ameliorate the survival and reduces recurrence and distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> in patients with <z:e sem="disease" ids="C0677948" disease_type="Neoplastic Process" abbrv="">colorectal cancer stages II</z:e> and III </plain></SENT>
</text></document>